205 related articles for article (PubMed ID: 16282533)
1. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat interaction with cyclin T1 represses mannose receptor and the bone morphogenetic protein receptor-2 transcription.
Caldwell RL; Lane KB; Shepherd VL
Arch Biochem Biophys; 2006 May; 449(1-2):27-33. PubMed ID: 16615932
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor.
Vigerust DJ; Egan BS; Shepherd VL
J Leukoc Biol; 2005 Apr; 77(4):522-34. PubMed ID: 15637102
[TBL] [Abstract][Full Text] [Related]
4. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene.
Pocsik E; Higuchi M; Aggarwal BB
Lymphokine Cytokine Res; 1992 Dec; 11(6):317-25. PubMed ID: 1335762
[TBL] [Abstract][Full Text] [Related]
5. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Tat represses transcription from the mannose receptor promoter.
Caldwell RL; Egan BS; Shepherd VL
J Immunol; 2000 Dec; 165(12):7035-41. PubMed ID: 11120831
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines.
Tosi G; De Lerma Barbaro A; D'Agostino A; Valle MT; Megiovanni AM; Manca F; Caputo A; Barbanti-Brodano G; Accolla RS
Eur J Immunol; 2000 Jan; 30(1):19-28. PubMed ID: 10602023
[TBL] [Abstract][Full Text] [Related]
9. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
Faller E; Kakal J; Kumar R; Macpherson P
Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 infection and regulation of Tat function in macrophages.
Liou LY; Herrmann CH; Rice AP
Int J Biochem Cell Biol; 2004 Sep; 36(9):1767-75. PubMed ID: 15183343
[TBL] [Abstract][Full Text] [Related]
11. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase.
Fotheringham J; Mayne M; Holden C; Nath A; Geiger JD
Virology; 2004 Oct; 327(2):186-95. PubMed ID: 15351206
[TBL] [Abstract][Full Text] [Related]
13. Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension.
Nasim MT; Ghouri A; Patel B; James V; Rudarakanchana N; Morrell NW; Trembath RC
Hum Mol Genet; 2008 Jun; 17(11):1683-94. PubMed ID: 18321866
[TBL] [Abstract][Full Text] [Related]
14. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
15. IL-16 represses HIV-1 promoter activity.
Maciaszek JW; Parada NA; Cruikshank WW; Center DM; Kornfeld H; Viglianti GA
J Immunol; 1997 Jan; 158(1):5-8. PubMed ID: 8977168
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.
Brock M; Trenkmann M; Gay RE; Michel BA; Gay S; Fischler M; Ulrich S; Speich R; Huber LC
Circ Res; 2009 May; 104(10):1184-91. PubMed ID: 19390056
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 tat protein modulates fibronectin expression in thymic epithelial cells and impairs in vitro thymocyte development.
Maroder M; Scarpa S; Screpanti I; Stigliano A; Meco D; Vacca A; Stuppia L; Frati L; Modesti A; Gulino A
Cell Immunol; 1996 Feb; 168(1):49-58. PubMed ID: 8599839
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of NGF-signaling and Egr-1 expression by Tat in neuronal cell culture.
Darbinian-Sarkissian N; Czernik M; Peruzzi F; Gordon J; Rappaport J; Reiss K; Khalili K; Amini S
J Cell Physiol; 2006 Sep; 208(3):506-15. PubMed ID: 16741963
[TBL] [Abstract][Full Text] [Related]
19. Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS.
Cupp C; Taylor JP; Khalili K; Amini S
Oncogene; 1993 Aug; 8(8):2231-6. PubMed ID: 8336945
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat triggers TGF-beta production and NK cell apoptosis that is prevented by pertussis toxin B.
Poggi A; Zocchi MR
Clin Dev Immunol; 2006; 13(2-4):369-72. PubMed ID: 17162379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
